remifentanil has been researched along with Demyelinating Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, SW; Hwang, MS; Jeong, HC; Kim, BS; Kim, SH; Park, ST | 1 |
1 other study(ies) available for remifentanil and Demyelinating Diseases
| Article | Year |
|---|---|
General anesthesia, using remimazolam, for the patient with myelin oligodendrocyte glycoprotein antibody associated disease (MOGAD): A case report.
Topics: Anesthesia, General; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Autoantibodies; Demyelinating Diseases; Humans; Male; Myelin-Oligodendrocyte Glycoprotein; Oligodendroglia; Remifentanil | 2022 |